Besides, its physiopathological role remains unknown owing to little study has been emerged regarding TMED3 in the tumor setting, with the exception of three relevant studies performed in prostate cancer [10], colon cancer [11] and liver cancer [12] in chronological order. The gene discussed is TMED3; the disease is prostate cancer.